In accordance with the Barcelona Clinic Liver Cancer staging system, 12 patients (40%) were classified as Stage B, while 18 patients (60%) were classified as Stage C. Median CD3 and CD68 counts were found to be 51.0 and 46.0 per 20,000 μm2, respectively. This evidence concerns the gene CD68 and liver cancer.